FIELD: biotechnology.
SUBSTANCE: biological agent for analysing the level of extracellular tumour DNA in biomaterial samples is described. The agent is a synthetic DNA fragment 88 base pairs long, presented in the form of two complementary DNA chains with the sequences SEQ ID NO: 1 and SEQ ID NO: 2. The agent is used as an exogenous control in the determination of extracellular tumour DNA in biomaterial samples. A kit for performing digital polymerase chain reaction is also described. The kit includes the described biological agent and forward and reverse oligonucleotide primers with the sequences SEQ ID NO: 3 and SEQ ID NO: 4, respectively, as well as an oligonucleotide fluorescently labelled probe with the sequence SEQ ID NO: 5. A method of analysing the level of extracellular tumour DNA in biomaterial samples for liquid biopsy is disclosed. Reagents from the described kit are added to the sample. DNA is isolated from biomaterial. Quantitative determination of extracellular tumour DNA and quantitative determination of the described agent are carried out. The DNA extraction coefficient used to normalize the level of extracellular tumour DNA is calculated.
EFFECT: invention can be used to improve the accuracy and reproducibility of quantitative analysis of the level of tumour DNA in biomaterial samples for liquid biopsy in cancer.
7 cl, 4 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF NON-INVASIVE DIAGNOSIS OF BLADDER CANCER BASED ON DETECTION OF TUMOR DNA IN BIOLOGICAL FLUIDS AND SET OF REAGENTS FOR ITS IMPLEMENTATION | 2023 |
|
RU2813669C1 |
| METHOD OF QUANTITATIVE DETERMINATION OF DNA OF HUMAN HERPES VIRUS 6A (HHV-6A) AND DNA OF HUMAN HERPES VIRUS 6B (HHV-6B) AND A SET OF OLIGONUCLEOTIDE PRIMERS AND A PROBE FOR ITS IMPLEMENTATION | 2022 |
|
RU2800995C1 |
| METHOD OF QUANTITATIVE DETERMINATION OF DNA OF HUMAN HERPES VIRUS 6A (HHV-6A) AND A SET OF OLIGONUCLEOTIDE PRIMERS AND A PROBE FOR ITS IMPLEMENTATION | 2022 |
|
RU2802931C1 |
| MINIMALLY INVASIVE METHOD FOR DETECTING SENSITIVITY OF PROSTATE TUMOURS TO RADIATION THERAPY BASED ON CHANGE IN BRCA2 AND RAD50 GENE COPYING | 2019 |
|
RU2728428C1 |
| METHOD OF QUANTITATIVE DETERMINATION OF DNA OF HUMAN HERPES VIRUS 6A (HHV-6A) AND DNA OF HUMAN HERPES VIRUS 6B (HHV-6B) AND A SET OF OLIGONUCLEOTIDE PRIMERS AND A PROBE FOR ITS IMPLEMENTATION | 2022 |
|
RU2800731C1 |
| KIT FOR DETERMINING THE ABUNDANCE OF THE APP GENE IN THE HUMAN GENOME | 2021 |
|
RU2789799C1 |
| METHOD FOR DETECTING BANDAVIRUS DABIEENSE (SFTSV) VIRUS RNA BY REAL-TIME RT-PCR | 2024 |
|
RU2831410C1 |
| SET OF OLIGONUCLEOTIDE PRIMERS AND FLUORESCENTLY LABELLED PROBES FOR IDENTIFYING THE EPIGENETIC MARKERS OF CERVICAL CANCER | 2021 |
|
RU2760573C1 |
| METHOD OF GENOTYPING TLR2 GENE USING RS5743708 POLYMORPHISM AND A SET OF OLIGONUCLEOTIDE PRIMERS AND PROBES FOR ITS IMPLEMENTATION | 2023 |
|
RU2805861C1 |
| METHOD OF GENOTYPING TLR1 GENE USING RS5743551 POLYMORPHISM AND A SET OF OLIGONUCLEOTIDE PRIMERS AND PROBES FOR ITS IMPLEMENTATION | 2023 |
|
RU2805859C1 |
